Matthias Aizenberg

Amid rising prevalence and societal impact, addressing Alzheimer's disease demands breakthroughs in research and treatment. The pioneering initiative by the Indiana University School of Medicine, through the TREAT-AD (Target Enablement to Accelerate Therapy Development for Alzheimer's Disease) drug

In a rapidly evolving healthcare landscape, the introduction of the Medicare CY 2026 Payment Rule is expected to reshape various aspects of the industry, particularly focusing on chronic care management and telehealth services. This rule brings both opportunities and challenges, forcing healthcare

Amid growing health crises and increasing global competition in pharmaceuticals, a novel FDA initiative aims to fast-track drug reviews by slashing approval times for essential medicines. Can this new approach significantly impact domestic drug manufacturing, or does it introduce unprecedented

The healthcare landscape is poised to undergo a seismic shift with the introduction of AI-enhanced whole-body MRI technology, promising to revolutionize preventive health screening. CoreViva, a pioneering diagnostic imaging clinic located in Newport Beach, California, is at the forefront of this

With over ten million people worldwide battling Parkinson's disease, the quest for a treatment that not only controls symptoms but also halts the progression of this neurological disorder is of immense importance. Roche's recent advancement of prasinezumab, developed with Prothena, into Phase 3

The pediatric imaging market, currently valued at $8.7 billion, has attracted significant attention due to its anticipated growth trajectory towards $18.1 billion by 2034. This remarkable expansion is driven in part by a projected compound annual growth rate of 7.7% from 2025 to 2034, indicating a

In a decisive leap toward revolutionizing gene therapy, ProBio has unveiled its cutting-edge facility in Hopewell, New Jersey. This facility is poised to become a key player in the production of high-quality plasmid, lentiviral, and adeno-associated viral vectors tailored for genomic medicine. With

In this engaging conversation with biopharma expert Ivan Kairatov, we delve into the complexities and innovations in treating brain metastases from ovarian cancer. Ivan shares insights from a recent study that evaluated the effectiveness of Gamma Knife Stereotactic Radiosurgery (GKSRS) in managing

The unforeseen impact of the COVID-19 pandemic initiated a global rush not only to discover vaccines but also to explore effective antiviral drugs capable of counteracting multiple coronaviruses. This effort has evolved beyond traditional scientific methods, incorporating surprising and innovative

Ivan Kairatov, a notable expert in biopharma with a rich background in tech and innovation within the industry, lends his insights on a recent groundbreaking study in human cell cycle regulation. The study, led by the team at EPFL, unveils how newly evolved genes are integral to the complex process